Lysinuric protein intolerance
- PMID: 1155480
- DOI: 10.1016/0002-9343(75)90358-7
Lysinuric protein intolerance
Abstract
Lysinuric protein intolerance (LPI), an autosomal recessive defect of diamino acid transport, is characterized chemically by renal hyperdiaminoaciduria, especially lysinuria, and by impaired formation of urea with hyperammonemia after protein ingestion. Our 20 patients thrived during breast-feeding, but ingestion of cow's milk caused diarrhea and vomiting. When able to select their diet, they rejected all protein-rich foods. They were short staturated and had weak atrophic muscles, osteoporosis, hepatomegaly and often splenomegaly. Four patients were mentally retarded. Fifteen patients had leukocyte counts below 4,000/mm3, and 17 patients had platelet counts below 150,000/mm3. Serum lactate dehydrogenase activity was constantly increased, and transaminase and aldolase activities were often increased. In the infants' livers, changes were only revealed by electron microscopy: increased and vesicular smooth endoplasmic reticulum, and abundance of glycogen particles in the hepatocytes. In the older patients, light microscopy demonstrated clearly limited areas where hepatocytes had large pale cytoplasm and small pyknotic nuclei. The diamino acids lysine, arginine and ornithine had plasma concentrations only one-third to one-half the normal mean; the renal clearances were clearly increased. Oral diamino acid loading tests suggested impaired intestinal absorption. Urea is built in the liver through transformation of ornithine to arginine, and cleavage of arginine to ornithine and urea. The addition of ornithine to an intravenous I-alanine loading prevented the hyperammonemia and normalized the urea production. Therefore, the diet has been supplemented with arginine, and more protein has been added. This therapy has lead to a remarkable catch-up growth in some patients. The pathophysiology of LPI is explained. Because of defective intestinal absorption and incrased renal loss, the diamino acids have a low plasma concentration. Their transport from plasma to hepatocytes is also impaired, and the liver becomes deficient in ornithine. This retards the urea cycle, and leads to postprandial hyperammonemia and protein aversion. The presence of the transport defect in the hepatocytes distinguishes LPI from other hyperdibasicaminoacidurias.
Similar articles
-
Renal handling of diamino acids in lysinuric protein intolerance.J Clin Invest. 1974 Jul;54(1):9-17. doi: 10.1172/JCI107753. J Clin Invest. 1974. PMID: 4600043 Free PMC article. Clinical Trial.
-
Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.Metabolism. 2003 Jul;52(7):935-8. doi: 10.1016/s0026-0495(03)00089-1. Metabolism. 2003. PMID: 12870174
-
Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.Intern Med. 1992 Jan;31(1):55-9. doi: 10.2169/internalmedicine.31.55. Intern Med. 1992. PMID: 1568044
-
Lysinuric protein intolerance: reviewing concepts on a multisystem disease.Am J Med Genet C Semin Med Genet. 2011 Feb 15;157C(1):54-62. doi: 10.1002/ajmg.c.30287. Epub 2011 Feb 9. Am J Med Genet C Semin Med Genet. 2011. PMID: 21308987 Review.
-
Conditional deficiencies of ornithine or arginine.J Am Coll Nutr. 1986;5(2):167-76. doi: 10.1080/07315724.1986.10720123. J Am Coll Nutr. 1986. PMID: 3088083 Review.
Cited by
-
A difficult diagnosis of lysinuric protein intolerance: association with glucose-6-phosphate dehydrogenase deficiency.J Inherit Metab Dis. 1991;14(5):833-4. doi: 10.1007/BF01799959. J Inherit Metab Dis. 1991. PMID: 1779632 No abstract available.
-
Delayed skeletal development and IGF-1 deficiency in a mouse model of lysinuric protein intolerance.Dis Model Mech. 2023 Aug 1;16(8):dmm050118. doi: 10.1242/dmm.050118. Epub 2023 Aug 17. Dis Model Mech. 2023. PMID: 37486182 Free PMC article.
-
Lysinuric protein intolerance mimicking N-acetylglutamate synthase deficiency in a nine-year-old boy.Mol Genet Metab Rep. 2021 Mar 13;27:100741. doi: 10.1016/j.ymgmr.2021.100741. eCollection 2021 Jun. Mol Genet Metab Rep. 2021. PMID: 33763330 Free PMC article.
-
Combined hyperlipidemia in patients with lysinuric protein intolerance.J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S145-50. doi: 10.1007/s10545-010-9050-5. Epub 2010 Feb 23. J Inherit Metab Dis. 2010. PMID: 20177788
-
Hyperdibasicaminoaciduria in a Turkish infant without evident protein intolerance.Eur J Pediatr. 1979 Apr 25;131(1):33-41. doi: 10.1007/BF00442783. Eur J Pediatr. 1979. PMID: 436855
MeSH terms
Substances
LinkOut - more resources
Full Text Sources